There is no such thing as a "proven, stable stock". Like the rest of your post, that's just so much pablum.
"Time and patience are your assets." Wait, I need to write that down. lol
"careful monitoring of the stock is critical". Wow, I'm so glad you gave me that pointer. Until I got that pointer, I was only going to "monitor" the stock, not "carefully monitor it". You just saved me.
Well, at least you did if he actually trades at all. I think he just may be a 12 year old down in the basement. But if he is a genuine trader, he SUCKS at it.
interialtrader is a rank amateur! His posts prove he lost a bundle of money on TTPH! Either that, or he is a complete fraud who actually doesn't trade at all but instead comes to this board seeking some kind of adoration.
You claimed you put me on ignore! You have just been caught in another lie!
Same as Baird presentation of few days ago. This is still in a downtrend. Not much cash left, ongoing loss, and risk of 80% selloff like TTPH, where potential upside is not more than 10% ... maybe not that given the market needs to re-test it's crash low.
"CEMP as a stock is technically broken at the moment and this recent downturn can only be attributed to the TTPH disaster. "
Wrong. The downtrend can be attributed to not only the TTPH disaster, but also the fact that the market has just started a major correction, maybe bear market, along with the fact that CEMP financials are very poor ... little cash left and on-going burn.
Well, consider this. Let's say the Phase III is successful, unlike that of TTPH. But how much upside would it have under that scenario. I'd argue little to none, and it whatever upside would be quickly faded. This stock is way overvalued. They have little cash left and are years from a marketed product even were they to have Phase III success. Plus, they would have competition to their drug. But, most of all, the general market is just starting a major correction, maybe bear market. Risk-on stocks like CEMP are the low hanging fruit for being ripped up by bears in such a market.
Wrong. TTPH fell to cash + 50%. That would be about 7 or 8 for CEMP. Then again, it could be argued TTPH had a partial success already on their drug. So maybe, by comparison, CEMP would go even closer to cash.
The market will go down whether they hike or not. A hike might even make the selloff less severe because the market hates uncertainty and putting off the hike just prolongs the pain.
Did she "shoot down" the short argument that the general market is in a correction and that risk-on stocks like CEMP are the first casualties in such a market? If you don't think this is true, how do you account for the fact that CEMP has been in a downtrend since the beginning of August, where a downtrend is defined as declining 13 day and 50 day moving averages? If the shorts have no sound arguments, why has the stock been in a downtrend since the general market correction began?